How to manage Impaired renal function with a GFR of 19?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Impaired Renal Function with GFR of 19

For a patient with a GFR of 19 mL/min/1.73m², renal replacement therapy should be initiated to preserve remaining kidney function and prevent complications of end-stage renal disease. 1

Blood Pressure Management

Blood pressure control is critical for preserving remaining kidney function:

  • Target systolic blood pressure should be <120 mmHg using standardized office BP measurement 1
  • First-line therapy should include an ACE inhibitor or ARB titrated to maximally tolerated dose 1, 2
  • Monitor serum creatinine and potassium frequently after initiation or dose adjustment of ACEi/ARB 1
  • Do not discontinue ACEi/ARB with modest and stable increases in serum creatinine (up to 30%) 1
  • Stop ACEi/ARB if kidney function continues to worsen or if refractory hyperkalemia develops 1

Medication Considerations with GFR of 19

  • Losartan can be used in patients with renal impairment without dose adjustment unless the patient is volume depleted 3
  • Lisinopril elimination is decreased with GFR <30 mL/min, requiring careful dosing and monitoring 4
  • Consider using potassium-wasting diuretics and/or potassium-binding agents to manage hyperkalemia while maintaining RAS blockade 1

Proteinuria Management

If proteinuria is present:

  • Target proteinuria reduction with maximum tolerated doses of ACEi/ARB 2
  • For persistent proteinuria despite treatment, consider intensifying dietary sodium restriction 1
  • Consider mineralocorticoid receptor antagonists in refractory cases, with careful monitoring for hyperkalemia 1

Edema Management

For patients with edema:

  • Use loop diuretics as first-line therapy 1
  • Twice daily dosing is preferred over once daily dosing 1
  • Consider longer-acting loop diuretics (bumetanide or torsemide) if furosemide is ineffective 1
  • For resistant edema, combine loop diuretics with thiazide diuretics for synergistic effect 1
  • Monitor for adverse effects including hypokalemia, hyponatremia, and worsening GFR 1

Dietary Modifications

  • Restrict dietary sodium to <2.0 g/day (<90 mmol/day) 1, 2
  • Protein intake should be approximately 0.8 g/kg/day 1
  • Normalize weight if overweight or obese 1
  • Consider plant-based protein sources rather than animal proteins 2

Metabolic Complications Management

  • Treat metabolic acidosis if serum bicarbonate <22 mmol/L 1
  • Consider statin therapy for hyperlipidemia, particularly in patients with other cardiovascular risk factors 1
  • Monitor nutritional status regularly by measuring body weight and serum albumin 1

Preparation for Renal Replacement Therapy

With a GFR of 19 mL/min/1.73m², the patient is at stage 4 chronic kidney disease and approaching stage 5:

  • Initiate discussion about modality of renal replacement therapy 1
  • If hemodialysis is planned, preserve veins suitable for vascular access placement 1
  • If transplantation is an option, refer for transplant evaluation 1
  • Consider initiating renal replacement therapy, especially if there is evidence of malnutrition that does not respond to nutritional intervention 1

Monitoring and Follow-up

  • Check blood pressure at every clinic visit, at least every three months 1
  • Monitor serum creatinine, potassium, and proteinuria every 1-2 weeks after initiation or dose increase of ACEi/ARB, then every 3 months 2
  • Monitor nutritional status by measuring body weight and serum albumin every three months 1
  • Screen for and manage dyslipidemias with measurements of triglycerides, LDL, HDL, and total cholesterol 1

Common Pitfalls to Avoid

  • Discontinuing ACEi/ARB prematurely due to modest increases in serum creatinine 5
  • Inadequate management of hyperkalemia leading to unnecessary discontinuation of renoprotective medications 1
  • Failing to counsel patients to hold ACEi/ARB and diuretics during periods of volume depletion (sick days) 1
  • Overlooking the need for renal replacement therapy planning at this advanced stage of CKD 1
  • Ignoring cardiovascular risk management, which is elevated in patients with severe CKD 2

By implementing this comprehensive approach to managing impaired renal function with a GFR of 19, you can help slow disease progression, manage complications, and prepare for the eventual need for renal replacement therapy.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Proteinuria Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.